Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03628352 · ClinicalTrials.gov registry record · Phase 1
Taste-masking Study for Tricaprilin in Sensory Panelists
A Phase 1 study, sponsored by Cerecin.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03628352: Completed Phase 1 study, sponsored by Cerecin.
NCT03628352 is a Phase 1 study that has completed, run by Cerecin. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03628352, a Phase 1 study, has completed, sponsored by Cerecin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is an open-label multiple-dose study of the taste profile of tricaprilin formulated as a powder for reconstitution.
Interventions
- DRUG Tricaprilin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-09-10 |
| Est. Completion | 2019-08-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03628352
The ClinicalTrials.gov registry entry for NCT03628352 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cerecin, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tricaprilin is the first listed.
NCT03628352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03628352 about?
NCT03628352 is a clinical study titled "Taste-masking Study for Tricaprilin in Sensory Panelists". This is an open-label multiple-dose study of the taste profile of tricaprilin formulated as a powder for reconstitution.
What is the current status of trial NCT03628352?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2018-09-10. Estimated completion is 2019-08-22.
What interventions are being tested in trial NCT03628352?
The interventions under investigation include: Tricaprilin (DRUG).
Who is sponsoring clinical trial NCT03628352?
This trial is sponsored by Cerecin, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.